Interview: How can a Bayesian framework support benefit risk assessment?

Posted by Cytel

May 30, 2017 8:06:00 AM

A recent paper The case for Bayesian methods in benefit-risk assessment: Overview and future directions (1)  co-authored by Cytel Senior Vice President Consulting  Yannis Jemiai and published in Therapeutic Innovation and Regulatory Science, tackles the critical issue of benefit risk assessment, and the part Bayesian approaches can play in resolving their challenges.

There is certainly an...

Read More

Topics: biostatistics, benefit risk assessment, Statistical Analysis, Bayesian Methods, Bayesian

The Cytel blog keeps you up to speed with the latest developments in biostatistics and clinical biometrics.  Sign up for updates direct to your inbox. You can unsubscribe at any time.


Posts by Topic

see all

Recent Posts